Background. Immunoglobulin (Ig)A proteases of Haemophilus influenzae are highly specific endopeptidases that cleave the hinge region of human IgA1 and also mediate invasion and trafficking in human respiratory epithelial cells, facilitating persistence of H. influenzae. Little is known about the expression of IgA proteases in clinical settings of H. influenzae infection.
Selected human mucosal pathogens express immunoglobulin (Ig) A proteases, which are strongly associated with virulence. IgA proteases are a striking example of convergent evolution because 3 independent lines of these highly specific postproline endopeptidases (serine, metallo-, and cysteine types) are present in human bacterial pathogens, indicating a key role for IgA proteases in the host-pathogen interaction [1] [2] [3] . Discovered 30 years ago, IgA proteases cleave the hinge region of human IgA1, dissociating its antigen-binding Fab domains from the Fc domain, thus inhibiting functions of IgA, such as agglutination, inhibition of bacterial adhesion to epithelial cells, and opsonization [1, 2, 4] . IgA proteases were named because of their specificity for human IgA1. Since then, IgA proteases have been demonstrated to contribute to bacterial infection by several additional mechanisms, including stimulating production of proinflammatory cytokines, altering tumor necrosis factor α signaling, and mediating intracellular persistence [5] [6] [7] .
After the discovery of IgA proteases, excellent work by several groups characterized the gene that encodes IgA protease and enzyme specificity in multiple strains [8] [9] [10] [11] [12] [13] [14] [15] . Understanding the role of IgA protease in disease is challenging because the enzyme is highly specific for human IgA1, precluding studies in animal models.
As a result, studies of IgA proteases of Haemophilus influenzae have stalled since the late 1990s. However, several recent compelling observations provide new evidence for IgA protease as a virulence factor for H. influenzae human respiratory tract infection, including (1) a strong association of IgA protease expression with disease [16] [17] [18] ; (2) the discovery of a second distinct IgA protease gene that cleaves human lysosomal-associated membrane protein and is associated with infection in chronic obstructive pulmonary disease (COPD) [7, 17] ; (3) the observation that IgA proteases partially mediate invasion and trafficking in human respiratory epithelial cells and are required for optimal intracellular persistence [7] ; and (4) the up-regulation of IgA protease during persistence of H. influenzae in the nasopharynx in a human experimental challenge model, indicating selective pressure for expression of IgA protease during early colonization [19] .
Several important questions regarding expression and cleavage specificity of IgA proteases require answers to elucidate its role in the pathogenesis of human respiratory tract infection. In particular, the variability of expression and of cleavage specificity of IgA proteases among clinical isolates of H. influenzae has been unexplained.
The goal of the present study is to elucidate the distribution of iga protease genes and assess the expression of IgA proteases in a rigorously characterized set of strains of H. influenzae collected longitudinally over 15 years from adults with COPD. We demonstrate that the H. influenzae genome has 2 alleles that encode IgA proteases (igaA and igaB); all strains have igaA, and 40% of strains have igaB. We further show that each allele expresses 2 variants of IgA proteases that cleave different sites of human IgA1 and that expression of these 4 forms of IgA protease varies among strains. Finally, we present direct evidence that each of the different forms of IgA protease is selectively expressed in the human airways during infection. These data clarify a robust and sometimes confusing literature on IgA proteases of H. influenzae of the past 3 decades, and they emphasize the importance of IgA proteases in the pathogenesis of human airway infection by H. influenzae.
MATERIALS AND METHODS
The study was approved by the institutional review boards of the University at Buffalo and the Veterans Affairs Western New York Healthcare System. Written, informed consent was provided by participants.
COPD Study Clinic
The COPD study clinic, described elsewhere [20] , is a prospective study started in 1994. Subjects were seen monthly and at suspected exacerbations. Rigorous clinical criteria determined whether patients were experiencing an exacerbation. At each visit expectorated sputum samples were collected. An exacerbation caused by H. influenzae was defined by the onset of clinical symptoms simultaneous with the acquisition of a new strain [20] .
Strains
H. influenzae were identified using standard techniques and were further distinguished from Haemophilus haemolyticus using monoclonal antibody 7F3. which recognizes an epitope on the P6 protein [21] (see Supplement for details). Strains used in this study were passaged twice from the original isolation from sputum. From April 1994 through March 2009, a total of 169 independent isolates were identified based on multilocus sequence typing [22] . Each isolate is the first acquisition of that strain for each patient. The duration of carriage for each strain was determined by subjecting strains recovered from monthly sputum cultures to multilocus sequence typing.
Determination of iga Genes in Strains
IgA protease genes were identified by polymerase chain reaction (PCR) using oligonucleotide primers specific for the variants of iga genes (see Supplement for details).
Determination of Expression of IgA Proteases
To assess in vitro expression of IgA proteases, the cleavage pattern of each strain was determined by immunoblot assays after incubation of bacterial culture supernatant with human IgA, as described elsewhere [13, 17] .
Analysis of Sputum Samples
Samples from subjects in the COPD Study Clinic were processed as described elsewhere [20, 23] . Fragments of IgA were purified from sputum supernatants by affinity chromatography and subjected to immunoblot assay with anti-human IgAconjugated antibodies [24, 25] . The IgA fragments were further characterized by determining N-terminal sequences.
Real-time PCR
Real-time quantitative PCR to assess iga gene transcription was performed as described elsewhere [7] .
Statistical Analyses
Analyses were done with SAS software, version 9.3 (SAS Institute). H. influenzae strains were classified as persistent if an individual carried the same strain for ≥6 months. We examined the association between presence or expression of a given iga gene with carriage for ≥6 months and exacerbation of COPD, using χ 2 test or Fisher exact tests, as appropriate.
RESULTS

Identification of Variants of the igaA Allele
To assess in vitro expression of IgA proteases, 169 independent, minimally passaged isolates of nontypeable H. influenzae cultured from the sputum of 78 adults with COPD longitudinally over 15 years were studied by determining the cleavage patterns by immunoblot assays after incubation of bacterial culture supernatant with human IgA1. Previous work showed that IgA proteases A and B each produced characteristic banding patterns of cleavage products of human IgA [17] . However, in assays to characterize the IgA proteolysis patterns of 169 strains, we observed unexpected patterns. Specifically, 17 strains that contained the igaA gene, but lacked the igaB gene, showed a proteolytic cleavage pattern that is characteristic of the IgA B protease ( Figure 1 , lanes 1 and 3). We considered 2 possibilities to explain this result. The first was that the strains might contain the igaB gene but its presence was missed by the primers used to probe genomic DNA. The second was that the igaA gene encoded an IgA protease that had a cleavage pattern indistinguishable from that of the IgA protease encoded by the igaB gene.
To distinguish between these possibilities, we engineered mutants by knocking out the igaA gene of strains 84P12H1 and 124P3H1, which both lacked a detectable igaB gene but showed an apparent IgA B protease cleavage pattern. The result in Figure 1 shows that knocking out the igaA gene eliminated all IgA protease activity in these 2 strains. The N-terminal amino acid sequence of the protein band that resulted from cleavage of IgA by strain 124P3H1 was identical to that of the IgA B protease of strain 11P6H (Table 1) . We conclude that the igaA gene in these strains encodes an IgA protease that has a proteolytic cleavage pattern that is identical to IgA B protease. We propose to name this gene igaA2 to distinguish it from the previously identified iga gene in strain Rd (GenBank accession No. X59800) [26] , which we propose to name igaA1 ( Figure 2 ).
Identification of Variants of the igaB Allele
We observed 2 proteolytic cleavage patterns among strains with the igaB gene. Figure 3 shows the proteolytic cleavage patterns of prototype strains 11P6H and 2019, along with mutants in which the igaA and igaB genes in these strains were individually knocked out. The N-terminal amino acid sequence of the protein band that results from cleavage by the igaB gene in strain 11P6H differs from that of strain 2019 (Table 1) . We propose to name the igaB gene of strain 11P6H igaB1 (GenBank accession DQ423203), previously identified as igaB [17] . We propose to name the igaB gene, of which strain 2019 is the prototype, igaB2 (GenBank accession No. KC607498). Figure 2 shows the proteolytic cleavage sites in the hinge region of human IgA1 of the IgA proteases encoded by igaA (igaA1 and igaA2) and igaB (igaB1 and igaB2). The igaA and igaB genes are located in separate regions of the H. influenzae genome, as reported elsewhere [17, 18] . 
Abbreviations: H. influenzae, Haemophilus influenzae; IgA, immunoglobulin A. a For each strain, the N-terminal amino acid sequence of the fragment from the in vitro assay of IgA protease is shown. Each sputum sample result represents the fragment recovered directly from a sputum sample from which H. influenzae was isolated. b X indicates an ambiguous residue. 
Distribution of iga Genes in COPD Strains of H. influenzae
Having identified 4 variants of IgA proteases encoded by 2 iga alleles, we designed primers to distinguish each of the variants of igaA and igaB by PCR in our set of 169 strains (see Supplement for details). We identified primers that distinguish among the variants, except we could not identify primers that reliably distinguished igaB1 and igaB2 by PCR. To distinguish igaB1 and igaB2 from each other, we used the observation that the region immediately upstream of the start codon of igaB2 has repeats not present upstream of igaB1. A 687 bp fragment that spans the start codon of igaB genes was amplified and sequenced. A varying number of TCAAAAT repeats was present upstream of igaB2, whereas igaB1 lacked upstream repeats. Therefore, to distinguish igaB1 and igaB2, the fragment upstream of igaB was amplified by PCR, and the sequence was determined.
An igaA gene is present in every strain. Of the 169 strains, 137 (81%) have igaA1 and 31 (19%) have igaA2 (Figure 4) . Of the 169 strains, 68 (40%) have an igaB gene, 49 (29%) have igaB1, and 19 (11%) have igaB2 (Figure 4) .
Expression of IgA Proteases
To assess expression of IgA proteases in vitro, we incubated broth culture supernatants of each of the 169 strains with human IgA1, and the resulting reactions were subjected to immunoblot assays, which were probed with anti human IgA. A total of 148 strains (88%) had IgA protease activity; thus, 21 strains did not express IgA protease under these conditions. One strain expressed 2 IgA proteases simultaneously (IgA protease A1 and B2).
To assess the effect of in vitro passage on expression of IgA proteases, we passaged selected strains with each of the 4 iga genes in vitro 5 times and tested them again for expression of IgA protease. In all cases, IgA protease expression patterns remained unchanged with in vitro passage (see Supplement for details).
The observation that igaA2 and igaB1 encode IgA proteases that cleave at the same site in the human IgA1 hinge region, and thus produce identical cleavage patterns, complicates determination of IgA protease expression in strains that express igaA2 and igaB1. For 9 strains with both genes and that expressed the IgA-A2/IgA-B1 cleavage pattern, we performed quantitative real-time PCR to assess transcription of the genes. In all 9 strains, the igaB1 gene transcription was approximately 100-fold greater than that of the igaA2 gene ( Figure 5 ). Figure 4 summarizes the distribution of the 4 IgA protease genes and their expression in 169 consecutive, independent strains isolated longitudinally from adults with COPD. All strains contain an igaA gene, but only 59% of strains express an IgA protease A. An igaB gene is present in 68 strains (40%) (49 igaB1 and 19 igaB2). Of strains with igaB1, 42 of 49 (86%) express IgA protease B1, whereas only 8 of 19 (42%) with igaB2 express IgA protease B2.
Expression of IgA Proteases in Vivo
To assess expression of IgA proteases during human infection, IgA fragments from sputum supernatants were affinity purified, subjected to immunoblot assays, and probed directly with anti human IgA to detect fragments of IgA. Thus, human IgA fragments detected in this assay represent cleavage that occurred in the human airways. A total of 81 sputum supernatants from samples that grew H. influenzae were studied; 49 samples lacked detectable IgA cleavage fragments. Others produced a variety of patterns in immunoblot assays, precluding reliance on banding patterns of immunoblot assays to identify specific IgA proteases. Thus, to identify the specificity of IgA proteases that cleaved IgA during human airway infection, we excised bands in the predicted molecular mass range of IgA fragments from blots of 20 sputum samples and subjected them to N-terminal amino acid sequence determination ( Figure 6 ).
Ten bands showed sequences consistent with known cleavage sites of oral streptococci, 3 yielded no clear sequence, 1 yielded IgA protease A1, and 6 yielded a sequence consistent with IgA protease B1 or A2 (B1 and A2 have identical cleavage sites). Analysis of the iga genes in the corresponding strains isolated from the sputum samples allowed us to conclude that 4 of these 6 strains expressed IgAB1 protease (the strains had the igaA1 variant), 1 expressed IgA protease A2 (the strain had no igaB gene), and 1 could be either IgA protease B1 or A2 because the strain had both genes. We conclude from these results that IgA proteases A1, A2, and B1 are expressed in the human airways of adults with COPD.
Association of Genes and Expression of Genes With Exacerbation and Duration of Carriage
Of the 169 strains, 75 were acquired simultaneous with the onset of symptoms of an exacerbation (exacerbation strain), and 94 were acquired with no change in symptoms (colonization strain). The igaB1 gene was more prevalent among exacerbation strains (28 of the 75 [37%]) compared with colonization strains (21 of 94 [22%]) (P = .03). None of the other iga alleles were associated with exacerbation or colonization. Expression of igaA1 was less common in exacerbation strains. Of the 137 strains with igaA1, 61 were exacerbation strains and 76 were colonization strains; igaA1 was expressed in 29 (48%) and 53 (70%) of exacerbation and colonization strains, respectively (P = .008). Expression of igA2, igaB1, or igaB2 did not significantly differ among exacerbation and colonization strains.
After eliminating 14 strains that were cultured at a patient's first visit or near the patient's last visit in the study, the duration of carriage was available for 155 of the 169 strains (see Supplement for details). Of 155 strains, 49 (32%) were carried for ≥6 months. The prevalence and expression of igaA1, igA2, igaB1, and igaB2 did not significantly differ by duration of carriage.
DISCUSSION
In this study, we demonstrate that the genomes of strains of H. influenzae have 2 alleles that encode IgA proteases (igaA and igaB) and that each allele has 2 variants of IgA proteases that cleave different sites of human IgA1. The work further shows that expression of these 4 forms of IgA protease varies among strains. Finally, we present direct evidence that each of the different forms of IgA protease is selectively expressed in the . The N-terminal sequence of the band noted by the box is shown aligned with the amino acid sequence of the hinge region of the α chain of human IgA1; the sequence corresponds to the cleavage pattern of IgA protease B1, which is expressed by strain 54P24H1 which was isolated from the sputum sample 54PS24.
human airways during infection. Although the results reveal a more complex picture of H. influenzae IgA proteases than previously understood, these data bring clarity to the literature on IgA proteases of H. influenzae of the past 3 decades. The observation that each of the variants is expressed during human infection emphasizes the importance of IgA proteases in the pathogenesis of human airway infection by H. influenzae.
The elucidation of expression of variants of IgA protease with differing proteolytic specificities explains the observation in several previous studies of IgA protease that show differing levels of IgA protease activity and differing IgA protease specificities among strains, including some strains that express >1 specificity [13] [14] [15] . Elucidating the basis of variability in IgA protease expression and cleavage specificity among isolates, particularly in view of the strong association of IgA protease with virulence [16] and the strong selective pressure for H. influenzae to express IgA protease [19] , provides a foundation for investigating the roles of distinct IgA proteases of H. influenzae in human infection.
Our present findings establish that the H. influenzae pangenome includes 2 alleles (igaA and igaB) that encode distinct IgA proteases. Each allele has 2 variants that encode IgA proteases with characteristic cleavage patterns (igaA1, igaA2, igaB1, and igaB2) (Figure 4) . Superimposed on the presence of 4 gene variants is the observation that expression of the IgA proteases also seems to be regulated. Of the 169 strains, 147 expressed a single IgA protease, 21 did not express IgA protease, and 1 expressed 2 IgA proteases simultaneously.
A variable number of repeats were identified upstream of the start codon of igaB2, providing evidence that expression igaB2 is regulated by slipped-strand mispairing. No repeats or obvious regulatory sequences are present upstream of the igaA1, igaA2 or igaB1 genes. Expression of these genes may be constitutive or may be regulated by other mechanisms. Previous work with our prototype strain, 11P6H, shows constitutive expression of igaA1 and igaB1 with approximately 10-fold higher level of transcription of igaB1 compared with igaA1 [7] . The present study demonstrated that in the case of strains that have both igaA2 and igaB1, igaB1 is expressed at an approximately 100-fold higher level than igaA2. These results suggest higher baseline expression of igaB compared with igaA. Alternatively, point mutations could place selected genes out of frame and interrupt expression. Finally, expression may be regulated by phase variable restriction modification systems, such as DNA methyltransferase [27, 28] . It is important to recognize that our results reflect expression under in vitro conditions, which differ from in vivo conditions.
To assess expression in vivo, we identified IgA protease cleavage fragments in sputum samples from adults with COPD, providing direct evidence for expression of IgA proteases A1, A2, and B1 in the human respiratory tract. The majority of the 81 sputum supernatant samples that we studied had no detectable IgA fragments by immunoblot assay. One must be cautious in interpreting these results to assess the frequency with which IgA proteases are expressed in the airways, because multiple factors other than lack of expression can explain an absence of cleavage fragments in expectorated sputum samples. These include binding of fragments to bacteria and/or mucin removed by centrifugation during processing of sputum supernatants, degradation by nonspecific proteases in sputum, and the low sensitivity of immunoblot assays. The importance of this novel observation is the demonstration of expression of each of the variants of IgA proteases in the airways during human infection.
We showed expression of 3 of 4 variants of IgA proteases (IgA1, A2 and B1) in human airways by demonstrating cleavage fragments of human IgA in sputum. The study of Poole et al [19] , who challenged human volunteers with a strain of H. influenzae that has the igaB2 gene, showed that persistence in the human upper airway resulted in up-regulation of igaB2, which shifted from phase-off expression in the challenge inoculum to phase-on during colonization of the human nasopharynx over 6 days. Thus, all 4 variants of IgA proteases of H. influenzae are expressed in the human respiratory tract.
The acquisition of a new strain of H. influenzae is associated with the onset of an exacerbation [20, 21] . We tested the hypothesis that specific iga genes and expression of specific iga genes were associated with exacerbation. The presence of the igaB1 gene was associated with the propensity to cause exacerbations, and expression of IgA protease A1 was associated with colonization. The duration of persistence of nontypable H. influenzae in the airways of adults with COPD shows substantial variation among strains [29] . We saw no association between expression of specific IgA proteases and duration of carriage of individual strains.
Multiple determinants account for a strain's capacity to cause exacerbations and persist in COPD airways, including host factors, particularly because COPD involves multiple pathological processes whose effects are modified by varying host susceptibilities [30] . Assessing the role of individual determinants of infection and carriage is further confounded by the enormous genetic heterogeneity among strains of H. influenzae [31] [32] [33] [34] [35] . We speculate that in view of the role of IgA proteases in invasion of host cells and levels of intracellular persistence, the variable expression patterns of IgA proteases influences the propensity of strains to cause exacerbations and to persist in respiratory epithelial cells, contributing to the marked differences in these characteristics among strains of H. influenzae in the setting of COPD. Discovered 30 years ago by virtue of their capacity to cleave the hinge region of human IgA1 with high specificity, IgA proteases have more recently been recognized as having a broader range of activity in mediating pathogenesis of human respiratory tract infection, particularly intracellular persistence. The present study establishes that (1) the H. influenzae genome contains 2 iga alleles, (2) each allele expresses 2 variants with specific proteolytic degradation specificities, (3) strains with the igaB1 variant gene are associated with the propensity of a strain to cause an exacerbation of COPD, (4) strains of H. influenzae show variable expression of IgA proteases, and (5) variants of IgA protease are expressed in the human respiratory tract during infection. These observations will be important in understanding the role of IgA proteases in the pathogenesis of H. influenzae respiratory tract infection.
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